|
Video: What is a Stock Split?
|
|
Eton Pharmaceuticals is a pharmaceutical company. Co.'s product portfolio is comprised of three categories: Orphan Drugs, which include Alkindi Sprinkle® (hydrocortisone granules), a granule hydrocortisone formulation for the treatment of Adrenocortical Insufficiency designed for use in children; Hospital Products, which include Biorphen® (phenylephrine HCl) that is indicated for the treatment of hypotension resulting primarily from vasodilation in the setting of anesthesia; and Royalty Products, which include Alaway® Preservative Free (ketotifen fumarate), a preservative-free ophthalmic product approved for the treatment of allergic conjunctivitis. According to our Eton Pharmaceuticals stock split history records, Eton Pharmaceuticals has had 0 splits. | |
|
Eton Pharmaceuticals (ETON) has 0 splits in our Eton Pharmaceuticals stock split history database.
Looking at the Eton Pharmaceuticals stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Eton Pharmaceuticals shares, starting with a $10,000 purchase of ETON, presented on a split-history-adjusted basis factoring in the complete Eton Pharmaceuticals stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
11/14/2018 |
|
End date: |
03/27/2024 |
|
Start price/share: |
$6.00 |
|
End price/share: |
$3.80 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-36.67% |
|
Average Annual Total Return: |
-8.16% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$6,332.68 |
|
Years: |
5.37 |
|
|
|
|
|